ArticleCells2012

ELISPOT Assay for Monitoring Cytotoxic T Lymphocytes (CTL) Activity in Cancer Vaccine Clinical Trials.

Anatoli M Malyguine et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.